Photocure Partner Asieris announces completion of enrollment for Hexvix Phase III clinical trial in China
Photocure ASA, the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals has communicated that it has completed patient enrollment for the Hexvix® Phase III bridging trial.
